Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 2
1956 1
1958 2
1959 1
1965 1
1966 4
1967 9
1968 1
1969 3
1970 4
1971 5
1972 9
1973 14
1974 18
1975 31
1976 17
1977 52
1978 41
1979 48
1980 37
1981 54
1982 41
1983 41
1984 63
1985 62
1986 51
1987 50
1988 32
1989 52
1990 44
1991 50
1992 44
1993 73
1994 73
1995 105
1996 108
1997 150
1998 129
1999 149
2000 180
2001 220
2002 290
2003 260
2004 217
2005 209
2006 181
2007 192
2008 183
2009 188
2010 149
2011 228
2012 209
2013 193
2014 193
2015 198
2016 155
2017 157
2018 149
2019 174
2020 168
2021 169
2022 64
2023 25
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

5,637 results

Results by year

Filters applied: . Clear all
Page 1
4-Aminobiphenyl.
National Toxicology Program. National Toxicology Program. Rep Carcinog. 2011;12:38-9. Rep Carcinog. 2011. PMID: 21829249 Free article. No abstract available.
Flurbiprofen-Associated Hemolytic Anemia.
Gulen M, Unver Koluman B, Avci A, Satar S. Gulen M, et al. Am J Ther. 2019 Nov/Dec;26(6):e723-e726. doi: 10.1097/MJT.0000000000000879. Am J Ther. 2019. PMID: 30418224 No abstract available.
The cost-effectiveness of irbesartan for hypertension.
Borghi C, Urso R, Cicero AF. Borghi C, et al. Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):199-207. doi: 10.1586/14737167.2015.1018894. Epub 2015 Feb 23. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25703678 Review.
Candesartan cilexetil: an update.
Joost A, Schunkert H, Radke PW. Joost A, et al. Expert Opin Pharmacother. 2011 Aug;12(11):1769-80. doi: 10.1517/14656566.2011.587000. Epub 2011 Jun 9. Expert Opin Pharmacother. 2011. PMID: 21651457 Review.
Drug interactions with irbesartan.
Marino MR, Vachharajani NN. Marino MR, et al. Clin Pharmacokinet. 2001;40(8):605-14. doi: 10.2165/00003088-200140080-00004. Clin Pharmacokinet. 2001. PMID: 11523726 Review.
Odanacatib for the treatment of osteoporosis.
Boggild MK, Gajic-Veljanoski O, McDonald-Blumer H, Ridout R, Tile L, Josse R, Cheung AM. Boggild MK, et al. Expert Opin Pharmacother. 2015;16(11):1717-26. doi: 10.1517/14656566.2015.1064897. Epub 2015 Jul 6. Expert Opin Pharmacother. 2015. PMID: 26149759 Review.
. . . and losartan was no better than placebo.
Messerli FH. Messerli FH. J Hum Hypertens. 1999 Oct;13(10):649-50. doi: 10.1038/sj.jhh.1000926. J Hum Hypertens. 1999. PMID: 10516732 Review. No abstract available.
[Current therapy: losartan].
Degaute JP, Sternon J. Degaute JP, et al. Rev Med Brux. 1997 Oct;18(5):335-8. Rev Med Brux. 1997. PMID: 9441330 Review. French.
Sonidegib for the treatment of advanced basal cell carcinoma.
Ramelyte E, Amann VC, Dummer R. Ramelyte E, et al. Expert Opin Pharmacother. 2016 Oct;17(14):1963-8. doi: 10.1080/14656566.2016.1225725. Epub 2016 Aug 29. Expert Opin Pharmacother. 2016. PMID: 27538055 Review.
5,637 results